Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEGFR1-A24-1084 and Gemcitabine in Advanced Pancreatic Cancer
NCT00683358Phase 2Unknown
- Sponsor
- The University of Tokyo
- Start
- May 2008
- Primary completion
- Apr 2009
- Modality
- Antisense DNA, Vaccines & Immunotherapeutics, Small Interfering RNA (siRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of VEGFR1-A24-1084 in pancreatic cancer (PC), sponsored by The University of Tokyo. Status: unknown.
02
Drugs
VEGFR1-A24-1084
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00683358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683358.